TELCON RF PHARMACEUTICAL. Inc. (200230.KQ) KOE

1,035.00

-1(-0.10%)

Updated at October 20 09:15AM

Currency In KRW

Valuation

Market Cap69.45B
Enterprise Value121.83B
P/E Ratio-0.49
PEG Ratio0.17
Price/Sales Ratio0.38
Price/Book Ratio0.19
Enterprise/Revenue1.5
Enterprise/EBITDA-5.72

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.62
Operating Margin-0

Management Effectiveness

Return On Assets-0.19
Return On Equity-0.33

Income Statement

Revenue37.87B
Revenue/Share3,413.72
Gross Profit10.31B
EBITDA-18.23B
Net Income-26.32B
Diluted EPS-2,224.63

Balance Sheet

Total Cash9.53B
Total Cash/Share861.4
Total Debt49.13B
Total Debt/Equity0.75
Current Ratio0.3
Book Value Per Share5,460.82

Price History

52-Week Change-81.98
52-Week High4,433.33
52-Week Low951.67
Moving Average 50 Days1,665.53
Moving Average 200 Days1,558.65

Statistics

Average Volume3.19M
Shares Outstanding14.86M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateDecember 10, 2024